Germline Genetics

Advances in germline genetics, and related therapeutic opportunities, present new opportunities and challenges in prostate cancer. Composed of leaders across multiple disciplines, the PCCTC Germline Genetics Working Group (GGWG) was formed in 2017 to create a collaborative clinical and research culture aligned around germline genetics and targeted therapeutics centered around patients with prostate cancer. GGWG members work to develop creative, scalable strategies to deliver high-quality personalized genetics care for patients with prostate cancer. Recent publications include: